Serveur d'exploration COVID et hydrochloroquine - Exploration (Accueil)

Index « Titre (en) » - entrée « consequences »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
consequence < consequences < consider  Facettes :

List of bibliographic references indexed by consequences

Number of relevant bibliographic references: 8.
Ident.Authors (with country if any)Title
000306 (2021) Pobitra Borah [Inde] ; Pran Kishore Deb [Jordanie] ; Balakumar Chandrasekaran [Jordanie] ; Manoj Goyal [Arabie saoudite] ; Monika Bansal [Arabie saoudite] ; Snawar Hussain [Arabie saoudite] ; Pottathil Shinu [Arabie saoudite] ; Katharigatta N. Venugopala [Afrique du Sud] ; Nizar A. Al-Shar'I [Jordanie] ; Satyendra Deka [Inde] ; Vinayak Singh [Afrique du Sud]Neurological Consequences of SARS-CoV-2 Infection and Concurrence of Treatment-Induced Neuropsychiatric Adverse Events in COVID-19 Patients: Navigating the Uncharted.
000859 (2020) Virginia Bellido [Espagne] ; Antonio Pérez [Espagne]Consequences of COVID-19 on people with diabetes.
000D62 (2020) Noemí Martínez-L Pez-De-Castro [Espagne] ; Marisol Samartín-Ucha [Espagne] ; Adolfo Paradela-Carreiro [Espagne] ; Antonio Pérez-Landeiro [Espagne] ; María Teresa Inaraja-Bobo [Espagne] ; Miriam Álvarez-Payero [Espagne] ; Inés Castro-Nú Ez [Espagne] ; Nerea García-Beloso [Espagne] ; David Robles-Torres [Espagne] ; Aida L Pez-L Pez [Espagne] ; Sonia González-Costas [Espagne] ; Belén Leboreiro-Enríquez [Espagne] ; Luis Otero-Millán [Espagne] ; Elena Yaiza Romero-Ventosa [Espagne] ; Cristina Casanova-Martínez [Espagne] ; Karina Lorenzo-Lorenzo [Espagne] ; Ana María Regueira-Arcay [Espagne] ; Cristina Vázquez-L Pez [Espagne] ; Cristina Martínez-Reglero [Espagne] ; Guadalupe Pi Eiro-Corrales [Espagne]Real-world prevalence and consequences of potential drug-drug interactions in the first-wave COVID-19 treatments.
000E48 (2020) Christine A. Peschken [Canada]Possible Consequences of a Shortage of Hydroxychloroquine for Patients with Systemic Lupus Erythematosus amid the COVID-19 Pandemic.
000F15 (2020) Francisco José Roma Paumgartten [Brésil] ; Ana Cecilia Amado Xavier De Oliveira [Brésil]Off label, compassionate and irrational use of medicines in Covid-19 pandemic, health consequences and ethical issues.
000F81 (2020) Dieudonné M. Mvumbi [Oman]Mass intake of hydroxychloroquine or chloroquine in the present context of the Covid-19 outbreak: Possible consequences in endemic malaria settings.
001478 (2020) Correction: Rapid Reporting and Dissemination of Results and Its Consequences Regarding the Use of Hydroxychloroquine for COVID-19.
001A08 (2020) Alfred H J. Kim [États-Unis] ; Jeffrey A. Sparks ; Jean W. Liew [États-Unis] ; Michael S. Putman ; Francis Berenbaum ; Alí Duarte-García ; Elizabeth R. Graef ; Peter Korsten ; Sebastian E. Sattui ; Emily Sirotich [Canada] ; Manuel F. Ugarte-Gil ; Kate Webb ; Rebecca GraingerA Rush to Judgment? Rapid Reporting and Dissemination of Results and Its Consequences Regarding the Use of Hydroxychloroquine for COVID-19.

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/CovidChloroV1/Data/Main/Exploration
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/Title.i -k "consequences" 
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/Title.i  \
                -Sk "consequences" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    CovidChloroV1
   |flux=    Main
   |étape=   Exploration
   |type=    indexItem
   |index=    Title.i
   |clé=    consequences
}}

Wicri

This area was generated with Dilib version V0.6.38.
Data generation: Sat May 22 17:02:32 2021. Site generation: Sat May 22 17:06:52 2021